African-Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 1, 2013, Pages 40-49

  Roberts, Lara N ^a   Patel, Raj K ^a   Chitongo, Paradzai ^a   Bonner, Lynda ^a   Arya, Roopen ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

deep vein thrombosis; ethnicity; thrombin generation

Indexed keywords

THROMBIN; THROMBOMODULIN;

ADULT; AFRICAN CARIBBEAN; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; BLOOD PROTEINS; CARIBBEAN REGION; CASE-CONTROL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; FLUOROMETRY; HUMANS; LONDON; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN; RECURRENCE; RISK; THROMBIN; THROMBOMODULIN; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 84871777675     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835a07fa     Document Type: Article

References (40)

1. White RH, Zhou H, Gage BF. Effect of age on the incidence of venous thromboembolism following major surgery. J Thromb Haemost 2004; 2:1327-1333. (Pubitemid 40186129)
2. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California. Thromb Haemost 2005; 93:298-305. (Pubitemid 40253735)
3. White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96:267-273. (Pubitemid 44377808)
4. Patel RK, Ford E, Thumpston J, Arya R. Risk factors for venous thrombosis in the black population. Thromb Haemost 2003; 90:835-838. (Pubitemid 37427852)
5. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE study. J Thromb Haemost 2003; 1:80-87.
6. Dilley A, Austin H, Hooper WC, El-Jamil M, Whitsett C, Wenger NK, et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks; infants, patients with venous thrombosis, patients with myocardial infarction and control subjects. J Clin Lab Med 1998; 132:452-455. (Pubitemid 28564700)
7. Jerrard-Dunne P, Evans A, McGovern R, Hajat C, Kalra L, Rudd AG, et al. Ethnic differences in markers of thrombophilia. Stroke 2003; 34:1821-1827.
8. Zakai NA, McClure LA. Racial differences in venous thromboembolism. J Thromb Haemost 2011; 9:1877-1882.
9. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect on von Willebrand factor on occurence of deep-vein thrombosis. Lancet 1995; 345:152-155.
10. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of Factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343:457-462. (Pubitemid 30646484)
11. Kraaijenhagen RA, in't Anker PS, Koopman MMW, Reitsma PH, Prins MH, van den Ende A, Buller HR. High plasma concentration of Factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83:5-9. (Pubitemid 30045467)
12. Dargaud Y, Trzeciak MC, Bordet J-C, Ninet J, Negrier C. Use of calibrated automated thrombography t/-thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006; 96:562-567. (Pubitemid 44782534)
13. van Hylckama Vleig A, Christiansen SC, Luddington R, Cannegieter SC, Rosendaal FR, Baglin TP. Elevated endogenous thrombin potential is associated with an increased risk of a first deep vein thrombosis but not with risk of recurrence. Br J Haematol 2007; 138:769-774. (Pubitemid 47313221)
14. ten Cate-Hoek AJ, Dielis AW, Spronk HM, van Oerle R, Hamulyak K, Prins MH, ten Cate H. Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost 2008; 100:240-245.
15. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006; 296:397-402. (Pubitemid 44127523)
16. Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost 2008; 6:1720-1725.
17. Tripodi A, Legnani C, Chantarangkul V, Cosmi B, Palareti G, Mannucci PM. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost 2008; 6:1327-1333. (Pubitemid 352016312)
18. Haidl H, Cimenti C, Lecschnik B, Zach D, Muntean W. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 2006; 95:772-775.
19. Rosenkranz A, Hiden M, Leschnik B, Weiss E-C, Schlemback D, Lang U, et al. Calibrated automated thrombin generation in normal uncomplicated pregancy. Thromb Haemost 2008; 99:331-337. (Pubitemid 351230963)
20. Segers O, Van Oerle R, Ten Cate H, Rosing J, Castoldi E. Thrombin generation as an intermediate phenotype for venous thrombosis. A proof-of-concept study. Thromb Haemost 2010; 103:114-122.
21. Lutsey PL, Folsom AR, Heckbert SR, Cushman M. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost 2009; 7:1639-1648.
22. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383. (Pubitemid 17055592)
24. Hemker HC, Giesen P, Al Dieri R, Regnault V, De Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15. (Pubitemid 37449290)
25. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2:1954-1959. (Pubitemid 40192749)
26. van Veen JJ, Gatt A, Cooper PC, Kitchen S, Bowyer AE, Makris M. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 2008; 19:183-189. (Pubitemid 351498720)
27. Bagot CN, Marsh MS, Whitehead M, Sherwood R, Roberts L, Patel RK, Arya R. The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. J Thromb Haemost 2010; 8:1736-1744.
28. Pieper CF, Rao KMK, Currie MS, Harris TB, Cohen HJ. Age, functional status, and racial differences in plasma D-dimers in community dwelling elderly persons. J Gerontol A Med Sci 2000; 55A:M649-M657. (Pubitemid 32010310)
29. Patel RK, Ford E, Thumpston J, Arya R. Coagulation factor levels and venous thrombosis in the black population. Thromb Haemost 2004; 91:828-830. (Pubitemid 38477470)
30. Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups. J Thromb Haemost 2006; 4:2629-2635. (Pubitemid 44741559)
31. Regnault V, Hemker HC, Wahl D, Lecompte T. Phenotyping the haemostatic system by thrombography potential for the estimation of thrombotic risk. ThrombRes 2004; 114:539-545. (Pubitemid 39422589)
32. Dielis AW, Castoldi E, Spronk HMH, Van Oerle R, Hamulyak K, Ten Cate H, Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6:125-131.
33. Zakai NA, Lutsey PL, Folsom AR, Heckbert SR, Cushman M. Total tissue factor pathway inhibitor and venous thrombosis. The longitudinal investigation of thromboembolism etiology. Thromb Haemost 2010; 104:207-212.
34. Koster T, Rosendaal FR, Reitsma PH, van Der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb Haemost 1994; 71:719-722. (Pubitemid 24177958)
35. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. Identifying unprovoked thromboembolism at low risk for recurrence who can discontinue anticoagulation. CMAJournal 2008; 179:417-426.
36. Schneider D, Lillenfield DE, Im W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality rates. J Natl Med Assoc 2006; 98:1967-1972. (Pubitemid 44955943)
37. Kearon C. The natural history of venous thromboembolism. Circulation 2003:107:I22-I30.
38. Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010; 8:1994-2000.
39. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003; 348:1170-1175. (Pubitemid 36337330)
40. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998; 63:1839-1851. (Pubitemid 30415746)